Literature DB >> 24103673

Moyamoya disease associated with asymptomatic mosaic Turner syndrome: a rare cause of hemorrhagic stroke.

Sunil Manjila1, Benjamin R Miller2, Anitha Rao-Frisch2, Balint Otvos1, Anna Mitchell3, Nicholas C Bambakidis1, Michael A De Georgia4.   

Abstract

Moyamoya disease is a rare cerebrovascular anomaly involving the intracranial carotid arteries that can present clinically with either ischemic or hemorrhagic disease. Moyamoya syndrome, indistinguishable from moyamoya disease at presentation, is associated with multiple clinical conditions including neurofibromatosis type 1, autoimmune disease, prior radiation therapy, Down syndrome, and Turner syndrome. We present the first reported case of an adult patient with previously unrecognized mosaic Turner syndrome with acute subarachnoid and intracerebral hemorrhage as the initial manifestation of moyamoya syndrome. A 52-year-old woman was admitted with a subarachnoid hemorrhage with associated flame-shaped intracerebral hemorrhage in the left frontal lobe. Physical examination revealed short stature, pectus excavatum, small fingers, micrognathia, and mild facial dysmorphism. Cerebral angiography showed features consistent with bilateral moyamoya disease, aberrant intrathoracic vessels, and an unruptured 4-mm right superior hypophyseal aneurysm. Genetic analysis confirmed a diagnosis of mosaic Turner syndrome. Our case report is the first documented presentation of adult moyamoya syndrome with subarachnoid and intracerebral hemorrhage as the initial presentation of mosaic Turner syndrome. It illustrates the utility of genetic evaluation in patients with cerebrovascular disease and dysmorphism.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mosaic Turner syndrome; genetics; moyamoya syndrome; subarachnoid hemorrhage

Mesh:

Year:  2013        PMID: 24103673     DOI: 10.1016/j.jstrokecerebrovasdis.2013.07.038

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  7 in total

1.  RNF213 rare variants in an ethnically diverse population with Moyamoya disease.

Authors:  Alana C Cecchi; Dongchuan Guo; Zhao Ren; Kelly Flynn; Regie Lyn P Santos-Cortez; Suzanne M Leal; Gao T Wang; Ellen S Regalado; Gary K Steinberg; Jay Shendure; Michael J Bamshad; James C Grotta; Deborah A Nickerson; Hariyadarshi Pannu; Dianna M Milewicz
Journal:  Stroke       Date:  2014-10-02       Impact factor: 7.914

2.  Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.

Authors:  Nadeem I Khan; Ali A Saherwala; Mo Chen; Sepand Salehian; Hisham Salahuddin; Babu G Welch; Marco C Pinho; Ty Shang
Journal:  Cerebrovasc Dis Extra       Date:  2019-12-12

Review 3.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

4.  Chiari I Malformation Associated with Turner Syndrome.

Authors:  Kamble Jayaprakash Harsha; Jeevan S Nair
Journal:  J Neurosci Rural Pract       Date:  2017 Apr-Jun

5.  Moyamoya associated with Turner syndrome in a patient with type 2 spinocerebellar ataxia-Occam's razor or Hickam's dictum: a case report.

Authors:  Paulo Ribeiro Nóbrega; Francisco Bruno Santana da Costa; Pedro Gustavo Barros Rodrigues; Thais de Maria Frota Vasconcelos; Danyela Martins Bezerra Soares; Jéssica Silveira Araújo; Daniel Aguiar Dias; Manoel Alves Sobreira-Neto; Anderson Rodrigues Brandão de Paiva; Pedro Braga-Neto; Fernando Kok; Eveline Gadelha Pereira Fontenele
Journal:  BMC Neurol       Date:  2022-10-08       Impact factor: 2.903

6.  Bioengineering an Artificial Human Blood⁻Brain Barrier in Rodents.

Authors:  Kimia Kamal; Ben Waldau
Journal:  Bioengineering (Basel)       Date:  2019-04-30

Review 7.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.